October Pharma S.A.E (EGX: OCPH)

October Pharma S.A.E Statistics

Total Valuation

October Pharma S.A.E has a market cap or net worth of EGP 1.30 billion. The enterprise value is 1.81 billion.

Market Cap	1.30B
Enterprise Value	1.81B

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	May 28, 2024

Share Statistics

October Pharma S.A.E has 12.00 million shares outstanding. The number of shares has decreased by -55.51% in one year.

Current Share Class	n/a
Shares Outstanding	12.00M
Shares Change (YoY)	-55.51%
Shares Change (QoQ)	-93.58%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	n/a
Float	1.38M

Valuation Ratios

The trailing PE ratio is 12.12.

PE Ratio	12.12
Forward PE	n/a
PS Ratio	1.87
PB Ratio	2.00
P/TBV Ratio	n/a
P/FCF Ratio	21.02
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.38, with an EV/FCF ratio of 29.23.

EV / Earnings	9.79
EV / Sales	1.51
EV / EBITDA	1.38
EV / EBIT	1.40
EV / FCF	29.23

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.86.

Current Ratio	1.58
Quick Ratio	0.40
Debt / Equity	0.86
Debt / EBITDA	0.42
Debt / FCF	8.98
Interest Coverage	11.46

Financial Efficiency

Return on equity (ROE) is 36.43% and return on invested capital (ROIC) is 77.11%.

Return on Equity (ROE)	36.43%
Return on Assets (ROA)	62.69%
Return on Capital (ROIC)	77.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.93
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.23%
50-Day Moving Average	116.49
200-Day Moving Average	104.12
Relative Strength Index (RSI)	25.44
Average Volume (20 Days)	1,125

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, October Pharma S.A.E had revenue of EGP 1.19 billion and earned 184.44 million in profits. Earnings per share was 8.93.

Revenue	1.19B
Gross Profit	1.48B
Operating Income	1.29B
Pretax Income	232.87M
Net Income	184.44M
EBITDA	1.31B
EBIT	1.29B
Earnings Per Share (EPS)	8.93

Balance Sheet

The company has 47.68 million in cash and 555.15 million in debt, giving a net cash position of -507.47 million or -42.29 per share.

Cash & Cash Equivalents	47.68M
Total Debt	555.15M
Net Cash	-507.47M
Net Cash Per Share	-42.29
Equity (Book Value)	648.62M
Book Value Per Share	54.05
Working Capital	413.71M

Cash Flow

In the last 12 months, operating cash flow was 98.96 million and capital expenditures -37.16 million, giving a free cash flow of 61.80 million.

Operating Cash Flow	98.96M
Capital Expenditures	-37.16M
Free Cash Flow	61.80M
FCF Per Share	5.15

Margins

Gross margin is 123.95%, with operating and profit margins of 107.88% and 18.12%.

Gross Margin	123.95%
Operating Margin	107.88%
Pretax Margin	19.52%
Profit Margin	18.12%
EBITDA Margin	109.71%
EBIT Margin	107.88%
FCF Margin	5.18%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.31%.

Dividend Per Share	2.50
Dividend Yield	2.31%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	25.81%
Buyback Yield	55.51%
Shareholder Yield	57.82%
Earnings Yield	8.25%
FCF Yield	4.76%

Stock Splits

The last stock split was on December 7, 2022. It was a forward split with a ratio of 2.

Last Split Date	Dec 7, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a